Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-016748
Filing Date
2026-05-13
Accepted
2026-05-13 16:31:24
Documents
58
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20260331_10q.htm   iXBRL 10-Q 1026776
2 EXHIBIT 31.1 ex_955984.htm EX-31.1 7999
3 EXHIBIT 31.2 ex_955985.htm EX-31.2 8000
4 EXHIBIT 32.1 ex_955986.htm EX-32.1 6117
  Complete submission text file 0001437749-26-016748.txt   4860027

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tlph-20260331.xsd EX-101.SCH 45840
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20260331_def.xml EX-101.DEF 301597
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20260331_lab.xml EX-101.LAB 269486
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20260331_pre.xml EX-101.PRE 328267
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlph-20260331_cal.xml EX-101.CAL 23621
62 EXTRACTED XBRL INSTANCE DOCUMENT acrx20260331_10q_htm.xml XML 668355
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

EIN.: 412193603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 26973930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)